Patent assignee · US · COMPANY

Curagen Corporation

93Patents
1Active
93Granted
37Portfolio score

Filing activity: Mar 31, 1995 → Dec 30, 2004 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6274320A Method of sequencing a nucleic acid Chemistry; Metallurgy 918 Expired
US5871697A Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing Emerging Cross-Sectional Technologies 246 Expired
US5972693A Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing Emerging Cross-Sectional Technologies 126 Expired
US6017434A Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments Emerging Cross-Sectional Technologies 110 Expired
US6236945A Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments Emerging Cross-Sectional Technologies 99 Expired
US6193866A Separation of charged particles by a spatially and temporally varying electric field Performing Operations; Transporting 71 Expired
US5993634A Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments Emerging Cross-Sectional Technologies 69 Expired
US6485625B1 Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments Physics 54 Expired
US5938904A Separation of charged particles by a spatially and temporally varying electric field Performing Operations; Transporting 54 Expired
US6083693A Identification and comparison of protein-protein interactions that occur in populations Physics 52 Expired
US6355423B1 Methods and devices for measuring differential gene expression Physics 48 Expired
US6418382B2 Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing Emerging Cross-Sectional Technologies 47 Expired
US6057101A Identification and comparison of protein-protein interactions that occur in populations and identification of inhibitors of these interactors Physics 45 Expired
US6486299B1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity Emerging Cross-Sectional Technologies 33 Expired
US6436642B1 Method of classifying a thyroid carcinoma using differential gene expression Chemistry; Metallurgy 33 Expired
US6141657A Method and apparatus for identifying classifying or quantifying DNA sequences in a sample without sequencing Emerging Cross-Sectional Technologies 31 Expired
US6875570B2 Proteins and nucleic acids encoding same Human Necessities 28 Expired
US6753314B1 Protein-protein complexes and methods of using same Chemistry; Metallurgy 27 Expired
US7276593B2 Proteins and nucleic acids encoding same Human Necessities 27 Expired
US8067544B2 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof Physics 26 Active
US6231812A Method and apparatus for indentifying, classifying, or quantifying protein sequences in a sample without sequencing Emerging Cross-Sectional Technologies 23 Expired
US6429303B1 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same Emerging Cross-Sectional Technologies 22 Expired
US7112668B2 Polypeptides and nucleic acids encoded thereby Chemistry; Metallurgy 18 Expired
US6013630A Atrial natriuretic factor mutants and ischemic stroke Physics 17 Expired
US6600019B2 Polypeptides and nucleic acids encoding same Human Necessities 16 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.